Skip to content

SANTIS PHARMA

Active
Public limited companyfounded 1981active for 45 yearsRue de l'Avenir 12, 4890 Thimister-Clermont, BelgiumKBO/BCE: BE 0421.562.592
Summary

The computed 12-month bankruptcy probability of SANTIS PHARMA is 1.7% (moderate). The 2025 annual accounts show equity of €640,449 and a net result of €1.2m. Equity remains stable across the filed financial years (±0.3% per year). The company has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
SANTIS PHARMAActiveChecked score 54/100
Risk analysis ReportCompare

History

On 1 April 1981, SANTIS PHARMA was incorporated.1 In 2026 the registered office moved to Thimister-Clermont.2 Total assets went from €2.6m in 2018 to €8.7m in 2025 and headcount from 7.3 to 33.7 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 09-09-2026
  3. 3National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
09-09
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 31-08-2026
  • Registered-office move, rue de l'avenir, 12 à 4890 THIMISTER-CLERMONT
28-04
NBB filing Annual accounts filed
financial year 2025 · unclassified schema
2025
31-12
Financial Highest result from 2018 to 2025net €1.2m ▲93.8%
Operating result €1.7m, net result €1.2m, both a record.
09-09
Gazette deed Resignation: SANTIS GROUP (director)
Appointments: Marc BREYER, Catherine DAUBY and 6 others · Permanent representative: Hélène GORIA · Power of attorney13 facts ▸
  • General meeting, 25-08-2025
  • Director resignation, SANTIS GROUP (director)
  • Director appointment, Marc BREYER (director)
  • Director appointment, Catherine DAUBY (director)
  • Director appointment, Pierre DETHIER (director)
  • Director appointment, Philippe GEORIS (director)
  • Director appointment, Maria HENNES (director)
  • Director appointment, Bernard LEMARCHAND (director)
  • Director appointment, Monique SCHMITZ (director)
  • Director appointment, SC PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT (director)
  • Permanent representative, Hélène GORIA
  • Other provision, “acceptance, acceptés” (deed in French)
  • +1 further fact in this act
19-05
NBB filing Annual accounts filed
financial year 2024 · unclassified schema
2024
31-12
Financial Equity above €5mequity €5.3m ▲643%
A profit in every financial year since 2018 builds equity to €5.3m.
23-07
Gazette deed Restructuring
Merger · Shareholding · Accounting effect13 facts ▸
  • General meeting, 28-06-2024
  • Other provision, “mise à disposition du projet de fusion, actionnaire unique” (deed in French)
  • Other provision, 14-04-2024, “absence de modification importante du patrimoine actif et passif” (deed in French)
  • Other provision, 14-04-2024, “absence de modification du patrimoine informée par organes d'administration des absorbées” (deed in French)
  • Other provision, “dispense d'état comptable, état comptable clôturé moins de 3 mois avant la date du projet de fusion” (deed in French)
  • Merger, “transfert assimilé à une fusion par absorption, intégralité du patrimoine,activement et passivement” (deed in French) (9 times)
  • Shareholding, 100 (10 times)
  • Accounting effect, 01-01-2024
  • Other provision, “décharge aux organes d'administration des absorbées, approbation par l'assemblée générale des actionnaires de l'absorbante des premiers comptes annuels établis…” (deed in French)
  • Other provision, “notaire soussigné, attention attirée sur la portée de l'article 12:15 du Code des Sociétés et des Associations” (deed in French)
  • Other provision, “absence d'émission d'actions et de rapport, opération assimilée à une fusion par absorption” (deed in French)
  • Other provision, “absence d'immeuble dans le patrimoine des absorbées” (deed in French)
  • +1 further fact in this act
16-07
NBB filing Annual accounts filed
financial year 2023 · full format
27-05
Gazette deed Restructuring
Merger · Shareholding · Accounting effect5 facts ▸
  • Merger, “dissolution sans liquidation, totalité de leur patrimoine, activement et passivement” (deed in French) (9 times)
  • Shareholding, “actions ou parts et autres titres conférant le droit de vote” (deed in French) (10 times)
  • Accounting effect, 01-01-2024
  • Other provision, “droits attribués aux associés ou actionnaires ayant des droits spéciaux et aux titulaires de titres autres que des parts ou actions, Toutes les actions émises p…” (deed in French)
  • Other provision, “avantage particulier attribué aux membres des organes d'administration des sociétés appelées à fusionner” (deed in French)
2023
31-12
Financial Equity above €500,000equity €712,461 ▲84%
A profit in every financial year since 2018 builds equity to €712,461.
22-05
NBB filing Annual accounts filed
financial year 2022 · full format
2022
15-07
NBB filing Annual accounts filed
financial year 2021 · full format
Show earlier events
2021
10-06
NBB filing Annual accounts filed
financial year 2020 · full format
2020
28-08
NBB filing Annual accounts filed
financial year 2019 · full format · 28 days late
2019
10-08
NBB filing Annual accounts filed
financial year 2018 · full format · 10 days late
2018
23-08
NBB filing Annual accounts filed
financial year 2017 · full format · 23 days late
2017
29-08
NBB filing Annual accounts filed
financial year 2016 · full format · 29 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 45 annual accounts filed, the latest 10 are here; all 45 are under Financials.
4 of 11 deeds read
About the unread acts

Of the 11 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 7 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure